These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27708429)

  • 1. Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode.
    Capelli D; Cerchia C; Montanari R; Loiodice F; Tortorella P; Laghezza A; Cervoni L; Pochetti G; Lavecchia A
    Sci Rep; 2016 Oct; 6():34792. PubMed ID: 27708429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the peroxisome proliferator-activated receptor gamma (PPARgamma) ligand binding domain complexed with a novel partial agonist: a new region of the hydrophobic pocket could be exploited for drug design.
    Montanari R; Saccoccia F; Scotti E; Crestani M; Godio C; Gilardi F; Loiodice F; Fracchiolla G; Laghezza A; Tortorella P; Lavecchia A; Novellino E; Mazza F; Aschi M; Pochetti G
    J Med Chem; 2008 Dec; 51(24):7768-76. PubMed ID: 19053776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists?
    Gani OA
    Cardiovasc Diabetol; 2008 Mar; 7():6. PubMed ID: 18355413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different binding and recognition modes of GL479, a dual agonist of Peroxisome Proliferator-Activated Receptor α/γ.
    dos Santos JC; Bernardes A; Giampietro L; Ammazzalorso A; De Filippis B; Amoroso R; Polikarpov I
    J Struct Biol; 2015 Sep; 191(3):332-40. PubMed ID: 26185032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of phytocannabinoids as novel dual PPARα/γ agonists by a computational and in vitro experimental approach.
    D'Aniello E; Fellous T; Iannotti FA; Gentile A; Allarà M; Balestrieri F; Gray R; Amodeo P; Vitale RM; Di Marzo V
    Biochim Biophys Acta Gen Subj; 2019 Mar; 1863(3):586-597. PubMed ID: 30611848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Basis for Anti-non-alcoholic Fatty Liver Disease and Diabetic Dyslipidemia Drug Saroglitazar as a PPAR α/γ Dual Agonist.
    Honda A; Kamata S; Satta C; Machida Y; Uchii K; Terasawa K; Nemoto A; Oyama T; Ishii I
    Biol Pharm Bull; 2021; 44(9):1210-1219. PubMed ID: 34471049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Basis for PPARs Activation by The Dual PPARα/γ Agonist Sanguinarine: A Unique Mode of Ligand Recognition.
    Tian S; Wang R; Chen S; He J; Zheng W; Li Y
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of peroxisome proliferator-activated receptor α activation by WY14643: a new mode of ligand recognition and receptor stabilization.
    Bernardes A; Souza PC; Muniz JR; Ricci CG; Ayers SD; Parekh NM; Godoy AS; Trivella DB; Reinach P; Webb P; Skaf MS; Polikarpov I
    J Mol Biol; 2013 Aug; 425(16):2878-93. PubMed ID: 23707408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insights into human peroxisome proliferator activated receptor delta (PPAR-delta) selective ligand binding.
    Batista FA; Trivella DB; Bernardes A; Gratieri J; Oliveira PS; Figueira AC; Webb P; Polikarpov I
    PLoS One; 2012; 7(5):e33643. PubMed ID: 22606221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scaffold-based pan-agonist design for the PPARα, PPARβ and PPARγ receptors.
    Zhang LS; Wang SQ; Xu WR; Wang RL; Wang JF
    PLoS One; 2012; 7(10):e48453. PubMed ID: 23119024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [PPARα-Ligand Binding Modes Revealed by X-ray Crystallography].
    Kamata S; Ishii I
    Yakugaku Zasshi; 2021; 141(11):1267-1274. PubMed ID: 34719550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors α/γ dual agonists.
    Fracchiolla G; Laghezza A; Piemontese L; Parente M; Lavecchia A; Pochetti G; Montanari R; Di Giovanni C; Carbonara G; Tortorella P; Novellino E; Loiodice F
    Bioorg Med Chem; 2012 Mar; 20(6):2141-51. PubMed ID: 22341573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular association model of PPARα and its new specific and efficient ligand, pemafibrate: Structural basis for SPPARMα.
    Yamamoto Y; Takei K; Arulmozhiraja S; Sladek V; Matsuo N; Han SI; Matsuzaka T; Sekiya M; Tokiwa T; Shoji M; Shigeta Y; Nakagawa Y; Tokiwa H; Shimano H
    Biochem Biophys Res Commun; 2018 May; 499(2):239-245. PubMed ID: 29567478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel PPARα/γ dual agonists by virtual screening, ADMET prediction and molecular dynamics simulations.
    Liu X; Jing Z; Jia WQ; Wang SQ; Ma Y; Xu WR; Liu JW; Cheng XC
    J Biomol Struct Dyn; 2018 Aug; 36(11):2988-3002. PubMed ID: 28853334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor α/γ ligand LT175.
    Piemontese L; Fracchiolla G; Carrieri A; Parente M; Laghezza A; Carbonara G; Sblano S; Tauro M; Gilardi F; Tortorella P; Lavecchia A; Crestani M; Desvergne B; Loiodice F
    Eur J Med Chem; 2015 Jan; 90():583-94. PubMed ID: 25497132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chemoinformatics search for peroxisome proliferator-activated receptors ligands revealed a new pan-agonist able to reduce lipid accumulation and improve insulin sensitivity.
    Sblano S; Cerchia C; Laghezza A; Piemontese L; Brunetti L; Leuci R; Gilardi F; Thomas A; Genovese M; Santi A; Tortorella P; Paoli P; Lavecchia A; Loiodice F
    Eur J Med Chem; 2022 May; 235():114240. PubMed ID: 35325635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New 2-(aryloxy)-3-phenylpropanoic acids as peroxisome proliferator-activated receptor α/γ dual agonists able to upregulate mitochondrial carnitine shuttle system gene expression.
    Laghezza A; Pochetti G; Lavecchia A; Fracchiolla G; Faliti S; Piemontese L; Di Giovanni C; Iacobazzi V; Infantino V; Montanari R; Capelli D; Tortorella P; Loiodice F
    J Med Chem; 2013 Jan; 56(1):60-72. PubMed ID: 23171045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
    Seethala R; Golla R; Ma Z; Zhang H; O'Malley K; Lippy J; Cheng L; Mookhtiar K; Farrelly D; Zhang L; Hariharan N; Cheng PT
    Anal Biochem; 2007 Apr; 363(2):263-74. PubMed ID: 17335769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of dual PPARα/γ agonists and their effects on lipid metabolism.
    Gao Q; Hanh J; Váradi L; Cairns R; Sjöström H; Liao VW; Wood P; Balaban S; Ong JA; Lin HY; Lai F; Hoy AJ; Grewal T; Groundwater PW; Hibbs DE
    Bioorg Med Chem; 2015 Dec; 23(24):7676-84. PubMed ID: 26616289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the metabolically active form of metaglidasen: improved synthesis and investigation of its peculiar activity on peroxisome proliferator-activated receptors and skeletal muscles.
    Laghezza A; Montanari R; Lavecchia A; Piemontese L; Pochetti G; Iacobazzi V; Infantino V; Capelli D; De Bellis M; Liantonio A; Pierno S; Tortorella P; Conte Camerino D; Loiodice F
    ChemMedChem; 2015 Mar; 10(3):555-65. PubMed ID: 25641779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.